Dr. Babak Litkouhi, MD

Dr. Litkouhi practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Litkouhi's NPI, 1003877002, was assigned on March 29, 2006. Dr. Litkouhi graduated from Icahn School Of Medicine At Mount Sinai in 2000. Dr. Litkouhi holds California license C160189.

Dr. Litkouhi's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Litkouhi's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Litkouhi is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Litkouhi to 1 more hospital and 1 medical group, each named with a free account. Dr. Litkouhi's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Litkouhi practices, 3 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Litkouhi's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Litkouhi is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Litkouhi's licenses on file in 4 states: California, Connecticut, New Jersey and Massachusetts.

Dmand AI lists hysterectomy and menopause among the conditions Dr. Litkouhi treats.

CMS data shows 361 Medicare services from Dr. Litkouhi across 5 procedure codes in 2024, for 144 Medicare patients. Medicare paid $31,547 for them.

CMS counts 144 Medicare patients who saw Dr. Litkouhi in 2024. The largest group is 65 to 74, with 68 patients. 72% of them have high blood pressure, and 66% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Litkouhi's median patient age at 61, with 99% women.

In 2024, Dr. Litkouhi wrote 139 Medicare Part D claims for 38 patients. 85% of them were for generic drugs. CMS names the drug for 55 of them, across 4 drugs with 11 or more claims each, at $2,749 in total drug cost. In 2021, CMS named 69 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Litkouhi for performance year 2024, reported as part of a group. Dr. Litkouhi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Litkouhi as offering telehealth. CMS counts 14 procedures of removal of the uterus by Dr. Litkouhi, more than 88% of the clinicians it reports for that procedure.

Dmand AI links 37 papers to Dr. Litkouhi, published from 2008 to 2025. 2018 was the busiest year, with 7. The most frequent topics are Ovarian Neoplasms, Cell Line, Tumor and Endometrial Neoplasms. Dr. Litkouhi has published most often in Gynecol Oncol. Dr. Litkouhi's most frequent co-authors are Elena S. Ratner, MD, Alessandro D. Santin, MD and Masoud Azodi, MD.

CMS Open Payments shows 30 general payments to Dr. Litkouhi from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 60% of the total. Abbvie Inc. paid the most, $3,355.

Dr. Litkouhi graduated from Icahn School Of Medicine At Mount Sinai in 2000.

Dr. Litkouhi is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. HMO plans come from the most carriers, 3. Check the plan with the practice before a visit.